Rigshospitalet
- Country
- 🇩🇰Denmark
- Ownership
- Private
- Established
- 1757-03-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rigshospitalet.dk
Clinical Trials
1.1k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (763 trials with phase data)• Click on a phase to view related trials
Feasibility and Safety of Home Blood Count Measurement and Transfusions in Patients With Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukaemia (AML)
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 15
- Registration Number
- NCT07062250
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Online Physical Activity and Health Counseling for Survivors of Childhood Acute Lymphoblastic Leukemia
- Conditions
- Acute Lymphoblastic Leukemia ALLChildhood Cancer SurvivorsExerciseRehabilitation Exercise
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 82
- Registration Number
- NCT07042932
Microvascular Profiling of Nodules in the Thyroid Gland
- Conditions
- Thyroid Nodular Disease
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 50
- Registration Number
- NCT07041307
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰Technical University of Denmark, Lyngby, Denmark
CABGpreHAB - a Feasibility Study Protocol
- Conditions
- Ischaemic Heart DiseasePrehabilitationCoronary Artery BypassFeasibility StudiesMultimodal InterventionAdult
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 50
- Registration Number
- NCT07035171
- Locations
- 🇩🇰
The Department of Heart and Lung Surgery, Copenhagen University hospital Rigshospitalet, Copenhagen, Denmark
The PAINN Study - a Pilot Cross Sectional Study
- Conditions
- Hospitalized PatientHome Mechanical VentilationPainPain Management
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 40
- Registration Number
- NCT06980987
- Locations
- 🇩🇰
Respirations center east, Copenhagen, Denmark
- Prev
- 1
- 2
- 3
- 4
- 5
- 196
- Next
News
Novel Trial Compares Low-Dose Thrombolysis Methods for Pulmonary Embolism Treatment
A groundbreaking clinical trial is investigating three different treatment approaches for intermediate-high risk pulmonary embolism (PE): standard heparin therapy, low-dose thrombolysis, and ultrasound-assisted thrombolysis (USAT). The study aims to enroll 210 patients and will evaluate the effectiveness of these interventions using refined Miller scores to measure thrombus reduction.
Glofitamab Plus Polatuzumab Demonstrates Durable Responses in Relapsed/Refractory LBCL
Glofitamab combined with polatuzumab vedotin shows high response rates and durable remissions in heavily pretreated relapsed/refractory large B-cell lymphoma (LBCL).
Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial
The phase 3 RUBY trial demonstrated that dostarlimab combined with carboplatin and paclitaxel significantly improved progression-free survival and overall survival in patients with advanced or recurrent endometrial cancer across multiple molecular subgroups.